Tuesday, August 4, 2026

AstraZeneca’s Elecoglipron: Can This New Weight Loss Pill Compete with GLP-1 Giants?

AstraZeneca's new weight-loss pill, elecoglipron, shows promising results in trials, competing with existing obesity treatments.

Novo Nordisk’s Oral Wegovy Hits 50,000 Weekly Scripts in 3 Weeks: Why 90% Are Paying Cash

Novo Nordisk's oral Wegovy gains popularity in the U.S., surpassing 50,000 prescriptions in three weeks, reshaping obesity treatment.

Casper EV Set for Global Domination: Exporting to 50 Countries

South Korea's Gwangju Global Motors held a ceremony today to commemorate the production of Casper Electric.

Tag: heartworm prevention

Moxidectin vs. Traditional Heartworm Preventatives: Which Offers Better Protection in 2026?

Reports of drug resistance in heartworm prevention highlight the need for moxidectin-based strategies to combat ML-resistant strains.

Top News

- Our Sponsors Ad -

Follow us